Europe Advanced Wound Care Market, By Product Type (Dressing, Devices and Accessories, Antimicrobial, Biologics, Graphics and Matrices , Topical Agents, and Others), Wound Type (Primary Wound Care, Secondary Wound Care, and Others), Wound Class (Class I, Class II, Class III, Class IV), End User (Hospitals, Wound Care Centers, Ambulatory Centers, Home Healthcare, Speciality Clinics, and Others) Application (Chronic Wounds and Acute Wounds), Distribution Channel (Direct Tenders And Retail) – Industry Trends and Forecast to 2031.
Europe Advanced Wound Care Market Analysis and Size
The advanced wound care market encompasses various components such as dressings, therapy devices, biologics, and other advanced interventions. Dressings range from innovative materials to promote healing, therapy devices include specialized equipment, and biologics involve the use of biological substances. These elements collectively contribute to advanced wound care solutions, addressing complex and chronic wounds.
Data Bridge Market Research analyses that the Europe advanced wound care market, which was USD 3,634.12 million in 2023, is expected to reach USD 5,705.39 million by 2031, at a CAGR of 5.8% during the forecast period 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Europe Advanced Wound Care Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016-2021)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product Type (Dressing, Devices and Accessories, Antimicrobial, Biologics, Graphics and Matrices , Topical Agents, and Others), Wound Type (Primary Wound Care, Secondary Wound Care, and Others), Wound Class (Class I, Class II, Class III, Class IV), End User (Hospitals, Wound Care Centers, Ambulatory Centers, Home Healthcare, Speciality Clinics, and Others) Application (Chronic Wounds and Acute Wounds), Distribution Channel (Direct Tenders And Retail)
|
|
Countries Covered
|
Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe.
|
|
Market Players Covered
|
Smith & Nephew plc (U.K.), 3M (U.S.), B. Braun SE (Germany), Medline Industries, Inc. (U.S.), Mölnlycke Health Care AB (Sweden), Hollister Incorporated (U.S.), Essity Aktiebolag (Sweden), ConvaTec Group PLC (U.K.), Baxter (U.S.), Brightwake Ltd. (U.K.), Coloplast Group (Denmark), Cardinal Health (U.S.), Kerecis (Iceland), Lohmann & Rauscher GmbH & Co. KG (Germany), MiMedx (U.S.), AVERY DENNISON CORPORATION (U.S.), Johnson & Johnson Services, Inc. (U.S.), Medtronic (Ireland), Zimmer Biomet (U.S.), Elkem ASA (Norway), TRIAGE MEDITECH PVT. LTD. (India), Integra LifeSciences (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Advanced wound care involves the use of innovative and sophisticated wound management techniques and products for the treatment of complex and chronic wounds. This specialized care includes the application of advanced dressings, therapies, and devices to accelerate the healing process and enhance overall wound management outcomes.
Europe Advanced Wound Care Market Dynamics
Drivers
- Increasing Incidence of Chronic Wounds
The escalating incidence of chronic wounds, attributed to factors such as diabetes, vascular diseases, and an aging population, fuels the demand for advanced wound care solutions. These advanced interventions, including specialized dressings, therapies, and devices, are crucial for effectively managing chronic wounds, promoting faster healing, and minimizing complications. As chronic wound prevalence rises, the necessity for innovative and effective wound care strategies becomes increasingly imperative in healthcare.
- Growing Awareness among Healthcare Professionals and Patients
With increased understanding of innovative wound care options, healthcare professionals and patients are more accepting of advanced solutions. This awareness not only enhances patient outcomes but also boosts demand for sophisticated wound care products and therapies. Education plays a pivotal role in fostering a positive shift towards advanced wound care practices within the healthcare landscape, contributing to improved treatment strategies and overall healthcare quality.
Opportunities
- Enhancing Care Through Personalization
Customized wound care, considering individual needs, comfort, and convenience, improves patient experiences and treatment outcomes. This aligns with the emphasis on patient-centered care, fostering trust and loyalty among those seeking advanced wound care solutions. The patient-centric approach reflects a commitment to providing personalized, effective, and compassionate care, contributing to overall healthcare quality.
- Telemedicine Integration for Remote Wound Care
Telemedicine integration in advanced wound care creates opportunities for remote monitoring and consultation. Through incorporating wound care into telehealth platforms, healthcare providers can remotely assess and manage patients' wounds, ensuring timely interventions. This approach enhances accessibility, particularly for individuals in remote or underserved areas, and enables personalized care delivery, improving overall patient outcomes and contributing to the evolution of healthcare services.
Restraints/Challenges
- Lack of Skilled Healthcare Professionals
The lack of skilled healthcare professionals in advanced wound care impedes market growth by limiting the successful implementation of these solutions. Insufficient training and expertise hinder the proper application and utilization of advanced wound care products, potentially leading to suboptimal patient outcomes. This constraint affects market expansion as healthcare providers may face challenges in realizing the full potential of advanced wound care, resulting in slower adoption and utilization within clinical settings.
- Limited Standardization Affecting the Consistency of Care
The lack of standardized protocols and guidelines in advanced wound care presents a challenge to market growth by causing variations in treatment approaches. Without established standards, healthcare providers may adopt diverse practices, affecting the overall consistency of care. This challenge impedes market expansion as the absence of uniform guidelines hinders streamlined implementation and may contribute to uncertainties in product usage and efficacy, limiting broader market acceptance.
This Europe advanced wound care market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Europe advanced wound care market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In July 2023, Coloplast announced the acquisition of Kerecis, aiming to broaden its wound care portfolio. This strategic move enhances Coloplast's position in the wound care market by incorporating Kerecis' innovative solutions. The acquisition enables Coloplast to provide a more comprehensive range of advanced wound care products, meeting diverse healthcare needs and fostering market growth
- In October 2022, 3M Health Care's 3M V.A.C. Therapy achieved a significant milestone with over 2,000 published, peer-reviewed medical journal studies. This milestone underscores the therapy's extensive clinical evidence, solidifying its position as the first and only negative pressure wound therapy (NPWT) solution to attain such a substantial body of published research, highlighting its efficacy and widespread adoption
- In September 2022, Evonik entered an agreement with Coopmed for the exclusive distribution of Epicite, a biosynthetic cellulose wound dressing, in the German market for chronic wound management. This collaboration enables Coopmed to distribute Epicite, providing advanced wound care solutions and enhancing Evonik's presence in the German medical technology sector
- In January 2022, Coloplast's acquisition of Triad Life Sciences bolsters Convatec's position in the US advanced wound care market. It provides access to a distinctive and complementary technological platform, amplifying innovation. The strategic move aims to enhance patient outcomes and advance wound treatment capabilities, solidifying Convatec's presence in the dynamic healthcare landscape
- In May 2020, Integra LifeSciences revealed positive clinical results for Integra Bilayer Wound Matrix (IBWM), a component of its regenerative technology portfolio employing collagen and amniotic products. These advancements, coupled with strategic initiatives from industry leaders, are anticipated to drive growth in the advanced wound care market
Europe Advanced Wound Care Market Scope
The Europe advanced wound care market is segmented on the basis of product type, wound type, wound class, end user, application, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product Type
- Dressing
- Foam Dressings
- Hydrocolloid Dressings
- Film Dressings
- Alginate Dressings
- Hydrogel Dressings
- Collagen Dressings
- Hydrofiber Dressings
- Superabsorbent Dressings
- Other Advanced Dressings
- Devices and Accessories
- NPWT Devices and Accessories
- Debridement Devices and Accessories
- Wounds Assessment and Monitoring Devices
- Antimicrobial
- Silver
- Non-silver
- Biologics
- Graphics and Matrices
- Topical Agents
- Others
Wound Type
- Primary Wound Care
- Secondary Wound Care
- Others
- Surgical and Traumatic Wounds
- Diabetic Foot Ulcers
- Pressure Ulcers
- Venous Leg Ulcers
- Burns
Wound Class
- Class I
- Class II
- Class III
- Class IV
End User
- Hospitals
- Wound Care Centers
- Ambulatory Centers
- Home Healthcare
- Speciality Clinics
- Others
Application
- Chronic Wounds
- Acute Wounds
Distribution Channel
- Direct Tenders
- Retail
Europe Advanced Wound Care Market Regional Analysis/Insights
The Europe advanced wound care market is analysed and market size insights and trends are provided by product type, wound type, wound class, end user, application, and distribution channel as referenced above.
The countries covered in the Europe advanced wound care market report are France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe,
Germany is expected to dominate the Europe advanced wound care market due to substantial investments by German manufacturers, particularly in the dressing segment. The prevalence of diabetes in the country contributes to a higher incidence of diabetic ulcers, further driving the demand for advanced wound care solutions and solidifying Germany's leading market position.
The U.K is anticipated to secure the second-highest market share in the Europe advanced wound care market. This is attributed to a growing geriatric population and the availability of favorable reimbursement scenarios, particularly in the dressing segment. These factors contribute to the prominence of the U.K. in advanced wound care management.
France is expected to lead as the third-largest market in the Europe advanced wound care segment, driven by a notable increase in chronic wound cases. The dressing segment is particularly influential, with rising demand for advanced wound care solutions, solidifying France's position in addressing and managing chronic wounds within the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The Europe advanced wound care market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Europe advanced wound care market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Europe advanced wound care market. The data is available for historic period 2016-2021.
Competitive Landscape and Europe Advanced Wound Care Market Share Analysis
The Europe advanced wound care market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to Europe advanced wound care market.
Some of the major players operating in the Europe advanced wound care market are:
- Smith & Nephew plc (U.K.)
- 3M (U.S.)
- B. Braun SE (Germany)
- Medline Industries, Inc. (U.S.)
- Mölnlycke Health Care AB (Sweden)
- Hollister Incorporated (U.S.)
- Essity Aktiebolag (Sweden)
- ConvaTec Group PLC (U.K.)
- Baxter (U.S.)
- Brightwake Ltd. (U.K.)
- Coloplast Group (Denmark)
- Cardinal Health (U.S.)
- Kerecis (Iceland)
- Lohmann & Rauscher GmbH & Co. KG (Germany)
- MiMedx (U.S.)
- AVERY DENNISON CORPORATION (U.S.)
- Johnson & Johnson Services, Inc. (U.S.)
- Medtronic (Ireland)
- Zimmer Biomet (U.S.)
- Elkem ASA (Norway)
- TRIAGE MEDITECH PVT. LTD. (India)
- Integra LifeSciences (U.S.)
SKU-